Literature DB >> 31266074

[Photorefractive Keratectomy (PRK) as a Procedure for Correction of Residual Refractive Errors after Radial Keratotomy].

Filip S Filev1, Robert Kromer2, Andreas Frings3, Darina Dragneva4, Tosho Mitov4, Daniela Mitova4.   

Abstract

BACKGROUND: A large number of myopic patients were treated by radial keratotomy (RK) in recent years. Despite being effective in many cases, the refractive results of this surgical intervention proved to be of limited predictability, and it frequently resulted in over- or under-correction in the long term. In this study, we discuss the intermediate and long-term results of a topography-guided photorefractive keratotomy (PRK) in a consecutive series of patients who were previously treated for myopia by radial keratotomy.
MATERIALS AND METHODS: In this retrospective case series, we examined the refraction and visual acuity in a consecutive series of patients-16 eyes-who were treated by PRK for residual refractive errors after radial keratotomy in the past. Mean follow up was 41 months (min. 9, max. 96).
RESULTS: All treated eyes showed an improvement in uncorrected visual acuity, and 56% had an improvement in corrected visual acuity. No serious or sight-threatening complications were recorded. Refraction was stable throughout the study period in all patients.
CONCLUSIONS: In this case series, photorefractive keratotomy was shown to be an effective treatment method for secondary ametropia after radial keratotomy. Apart from the correct planning and execution of the PRK, it is of critical importance to inform the patients about the limitations and the anticipated refractive result of the procedure. Thieme. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31266074     DOI: 10.1055/a-0901-7544

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  1 in total

1.  Intraocular lens power calculation after two different successive corneal refractive surgeries.

Authors:  Zongsheng Zeng; Xiangyu Ye; Qingzhong Chen; Changkai Jia; Guangbin Zhang
Journal:  Am J Ophthalmol Case Rep       Date:  2022-04-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.